Clinical pharmacology, physiology and pathophysiology of superficial veins--1.

scientific article

Clinical pharmacology, physiology and pathophysiology of superficial veins--1. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2125.1994.TB04341.X
P932PMC publication ID1364788
P698PubMed publication ID7826819
P5875ResearchGate publication ID15372040

P2093author name stringAellig WH
P2860cites workClinical pharmacology, physiology and pathophysiology of superficial veins--2Q34346189
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
pathophysiologyQ1135939
P304page(s)181-196
P577publication date1994-09-01
P1433published inBritish Journal of Clinical PharmacologyQ176044
P1476titleClinical pharmacology, physiology and pathophysiology of superficial veins--1.
P478volume38

Reverse relations

cites work (P2860)
Q77360278Amiodarone causes endothelium-dependent vasodilation in human hand veins in vivo
Q35030731Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications
Q33146896Autonomic control of the venous system in health and disease: effects of drugs
Q70904626Autonomic dysreflexia in tetraplegic patients: evidence for alpha-adrenoceptor hyper-responsiveness
Q34777529Cardiac changes induced by immersion and breath-hold diving in humans
Q34334935Clinical pharmacology of alpha1A selective and nonselective alpha1-blockers
Q41987112Comparison of the effects of desipramine on noradrenaline- and methoxamine-evoked venoconstriction in man.
Q28367565Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man
Q71766493Cumulative and noncumulative dose-response curves to noradrenaline on the dorsal hand vein
Q33955008Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype.
Q43724984Diameter, pressure and compliance relationships in dorsal hand veins
Q52306427Direct angiotensin converting enzyme inhibitor-mediated venodilation.
Q35027775Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo.
Q71220601Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline
Q73794611Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans
Q73794607Familial studies of heritability of alpha1-adrenergic receptor responsiveness in superficial veins
Q37067189Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans
Q50522005Heparin attenuates norepinephrine-induced venoconstriction.
Q28385491Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo
Q44412672Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome
Q44856244Magnesium-induced vasodilation in the dorsal hand vein
Q34234030Measurement of body venous tone
Q56832856Neuropeptide Y in human hand veins: Pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo*
Q44310019Prostaglandin modulation of venoconstriction to physiological stress in normals and heart failure patients
Q73198479Relaxation induced by cGMP phosphodiesterase inhibitors sildenafil and zaprinast in human vessels
Q44362842Reproducibility of dorsal hand vein responses to phenylephrine and prostaglandin F2 alpha using the dorsal hand vein compliance method.
Q36053315The effects of age on human venous responsiveness to neuropeptide Y.
Q48483109Vascular endothelial dysfunction in patients with mild obstructive sleep apnea syndrome
Q46488675Venous endothelial function in heart failure: comparison with healthy controls and effect of clinical compensation
Q46917883Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients?

Search more.